|
|
|
|
Genomics |
|
 | | |
| This project explored the ethics of embryo research and assisted conception as experienced by professionals working in these fields, in both the public and private sectors. We explored professionals’ accounts of their values and how they actively negotiated ethical codes and rules in the course of their day-to-day work. We were especially interested in how practitioners managed the codes and rules set out by the Human Fertilisation and Embryology Authority (HFEA), public concerns about their work, and their own informal ‘moral thinking’. The project was based on three periods of observation, at an embryo research laboratory and at two IVF clinics, as well as fifty-two interviews with clinicians, scientists, nurses, counsellors, administrators and representatives of the HFEA. | Professor Anne Kerr
School of Sociology and Social Policy
University of Leeds
Leeds LS2 9JT
E.A.Kerr@leeds.ac.uk
0113 3437380 | Professor Henry Leese
Department of Biology
University of York
Heslington
York
YO10 5DD | Start date - May 2004 |
 | |
|
| | |
| This project investigated the attitudes, intentions and practices of farmers regarding the new technology of GM crops (both those with experience of them and those without) in relation to their social setting. The relationship building research approach we developed had three phases that used three different, and progressively more interactive, discussion and mapping techniques to engage with (often the same) participants. | Dr Andy Lane,
Department of Development Policy and Practice,
The Open University
Walton Hall,
Milton Keynes,
MK7 6AA
a.b.lane@open.ac.uk | Dr S M Oreszczyn,
Department of Development Policy and Practice,
The Open University
Walton Hall
Milton Keynes
MK7 6AA
Dr S Carr,
Centre for Complexity and Change,
The Open University
Walton Hall
Milton Keynes
MK7 6AA | Ended April 2007 |
| |
|
| | |
| New therapeutic interventions based on pharmacogenetics/pharmacogenomics have important implications for patient care and health delivery systems, as indicated in the recent Department of Health White Paper. The principal aim of this study is to advance our knowledge and theoretical understanding of the factors influencing the uptake and incorporation into clinical practice of new technologies based on pharmacogenetic and pharmacogenomic concepts of therapeutic intervention. | Dr Graham Lewis,
Science and Technology Studies Unit,
Department of Sociology,
University of York,
Heslington,
Yo10 5DD
gl12@york.ac.uk
| | Ended November 2006 |
| |
|
| | |
| This pilot project aimed to develop methods for understanding the impact of new security policies on the practice of science in the UK. It examined the effects of legal measures, introduced since 2001, which seek to secure legitimate biological research performed in the UK from misuse in the production and development of biological weapons. 64, of an initial sample of 128 UK-based scientists, funders of science, biosafety officials and security officials were asked about their perceptions of biological weapons issues; the impact of these regulations; any positive or negative effects on their work; interactions with policy makers; and various possibilities to improve biosecurity. | Dr Paul Nightingale
SPRU - Science and Technology Policy Research
Freeman Centre,
University of Sussex,
Falmer,
Brighton,
BN1 9RE
p.nightingale@sussex.ac.uk
| Dr Caitriona McLeish,
SPRU - Science and Technology Policy Research
Freeman Centre,
University of Sussex,
Falmer,
Brighton,
BN1 9RE
c.a.mcleish@sussex.ac.uk
| Ended September 2004 |
| |
|
| | |
| Export controls are central to one of the four pillars of the UK security strategy to counter the threat posed by biological weapons: namely preventing supply. (The other three pillars are arms control, deterring use, and defending against use.) | Dr Jez Littlewood
Mountbatten Centre for International Studies, University of Southampton
Southampton
SO17 1BJ
j.littlewood@soton.ac.uk
| | Ended December 2005 |
| |
|
|
|
|
|
|